Profil
Ram Waisbourd worked as VP-Strategy, Transformation & Global Research at Teva Pharmaceutical Industries Ltd.
from 2016 to 2018.
Prior to that, he was Vice President-Business Development at XTL Biopharmaceuticals Ltd.
Mr. Waisbourd's most recent job was as Chief Operating & Business Officer at 89bio, Inc. from 2018 to 2022.
Mr. Waisbourd holds an MBA from Tel-Aviv University and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Ram Waisbourd
| Sociétés | Poste | Fin |
|---|---|---|
| 89BIO, INC. | Chief Operating Officer | 01/06/2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Tech/Sci/R&D Officer | 01/04/2018 |
| XTL BIOPHARMACEUTICALS LTD. | Corporate Officer/Principal | - |
Formation de Ram Waisbourd
| Tel-Aviv University | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| 89BIO, INC. | Health Technology |
